Pills2Me
Techstars '22Las Vegas, US · Founded 2020 · 11 employees on LinkedIn · 2 known investors
Find your way into Pills2Me
2,419 people in our graph can introduce you to the Pills2Me team.
Sign up to see every warm intro you have to Pills2Me
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pills2Me team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Pills2Me is a prescription delivery service that picks up medications from any pharmacy and delivers them to customers' doors within two hours. The platform is HIPAA-compliant, pharmacist-founded, and includes an AI assistant for ordering and live pharmacist support.
Also known as Pills2Me (Techstars NYC '22)
Founders & leadership
Pills2Me was founded in 2020 by Leslie Asanga.

Investors · 2
How we know: Jumpstart Foundry's portfolio page · Not right? Tell us
How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
Company profile
researched Sep 2026Pills2Me is a Las Vegas-based health technology company offering on-demand prescription delivery from any pharmacy — independents, chains and hospital pharmacies — to a patient's home, office or other address. Patients place orders through an iOS/Android app or by phone, a vetted courier collects the filled prescription at the pharmacy counter, and the delivery is tracked end to end with in-app messaging to the driver. The company states a guaranteed two-hour delivery window and cites an average delivery time of roughly 30 minutes. Alongside prescriptions, the app sells over-the-counter products through an in-app pharmacy storefront, offers live chat with licensed pharmacists, and lists medication therapy management (MTM) pharmacies.
The platform's more recent addition is an AI assistant that lets patients order, track deliveries, and request refills by voice or text in over 50 languages, positioned for older adults, non-technical users and patients with disabilities. The company says the assistant handles logistics only, with licensed pharmacists available in-app for clinical questions, and that it runs on HIPAA-compliant infrastructure. App release notes also describe a diabetes risk assessment that refers users to CDC-approved institutions, driver onboarding tooling, pharmacy batch orders and route optimization.
Beyond direct-to-patient service, Pills2Me markets itself to four institutional stakeholder groups: retail and independent pharmacies (reducing return-to-stock on unclaimed fills and adding OTC attach), health plans (on-demand delivery as a covered member benefit tied to adherence, HEDIS and Star Ratings measures), telehealth companies (closing the loop between a virtual visit and a filled script), and health systems (a meds-to-beds style discharge delivery without expanding outpatient pharmacy staffing).
Founding story
Pills2Me was founded by pharmacist Leslie Asanga, who is originally from Cameroon, after observing seniors and immunocompromised patients struggle to obtain medications during the COVID-19 pandemic. The initial service delivered medications to those groups; the customer base later broadened to patients with transportation barriers and consumers who simply prefer delivery.
Business model
Pills2Me operates a two-sided last-mile logistics platform: patients order deliveries through the consumer app or phone line, while pharmacies, health plans, telehealth companies and health systems contract with the company for courier fulfillment. Couriers are background-checked and HIPAA-trained and are dispatched on demand to the pharmacy counter. Partner pharmacies gain delivery capability without hiring drivers, buying vehicles or adding payroll, and receive exposure to Pills2Me app users in their area plus OTC sales through the in-app pharmacy.
Public materials describe consumer delivery orders (with promotional free first deliveries), OTC product sales through an in-app pharmacy storefront, and partner programs for pharmacies, health plans, telehealth companies and health systems; specific pricing is not disclosed.
Traction
The company's site claims over 1,000,000 prescriptions delivered and an average delivery time of about 30 minutes. The iOS app holds a 3.9 rating from 78 ratings and has shipped frequent updates, most recently version 3.0.2 in September 2025. As of July 2023 the company operated in four markets — Las Vegas, Chicago, Houston and New Haven, Connecticut — and had announced plans to launch in Reno, Phoenix, Dallas, San Antonio, Miami and Tampa by the end of 2023. A partner pharmacy testimonial comes from Las Vegas Scripts Pharmacy.
Latest developments
The company launched an AI assistant for voice and text prescription ordering, refills and tracking in 50+ languages, integrated across the app and website, with app releases in 2025 adding a driver assistant, Siri-based reordering and iOS 27 support (version 3.0.2, September 2025). It also expanded B2B positioning across pharmacies, health plans, telehealth companies and health systems, and promotes a partner pharmacy program with onboarding in as little as three business days.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Positioned as pharmacy-agnostic last-mile infrastructure that works with existing retail pharmacies rather than shifting patients to mail order or a captive pharmacy, emphasizing pharmacist founding, HIPAA compliance and nationwide retail density. The company frames its value against medication non-adherence, which it cites as an estimated $300 billion in avoidable annual U.S. healthcare spend.
Works with any pharmacy — independents, chains and hospital pharmacies — so patients and payers avoid switching to mail order or a specific chain; founded and process-vetted by licensed pharmacists; HIPAA-compliant couriers and platform; in-app access to live licensed pharmacists; and a multilingual voice/text AI ordering assistant designed for accessibility.
Technology
A proprietary dispatch and delivery platform covering courier matching, live order tracking, proof of delivery, route optimization and pharmacy batch orders, described by the founder as able to handle tens to hundreds of thousands of orders a day. The consumer app adds an AI assistant supporting voice and text ordering, refills and delivery tracking in 50+ languages, a Siri reorder bridge, and a driver-facing assistant. The company states HIPAA-compliant infrastructure across drivers, workflows and data.
Go-to-market
Direct-to-consumer acquisition via the Pills2Me iOS/Android app and a phone ordering line, combined with B2B sales through a partner pharmacy program and demo booking for health plans, telehealth companies and health systems. Pharmacy onboarding is delivered white-glove by a named specialist, with most pharmacies live in as little as three business days and no new software or hardware required. Local landing pages target markets such as Las Vegas and Houston.
Patients who cannot easily reach a pharmacy — seniors, immunocompromised and self-isolating people, caregivers, patients without transportation, and people who prefer delivery — plus institutional buyers: independent and chain pharmacies, hospital and health-system discharge programs, health plans and telehealth platforms.
Geography
Headquartered in Las Vegas, Nevada. Operating markets reported in July 2023 were Las Vegas, Chicago, Houston and New Haven, Connecticut, with six additional markets planned (Reno, Phoenix, Dallas, San Antonio, Miami, Tampa). Current site content references local service in Las Vegas and Houston and a stated nationwide pharmacy network ambition.
History
Founded in 2020 in Las Vegas during the pandemic as a delivery service for seniors and immunocompromised patients. The iOS app has shipped updates continuously since 2021. In July 2023 the company reported operating in four U.S. markets, received a Google for Startups Black Founders Fund award, and said that award closed its pre-seed round, with plans to resume fundraising in 2024. Later product work added medication therapy management listings, pharmacy batch ordering, a diabetes risk assessment, and an AI ordering assistant.
Risks & controversies
Recent App Store reviews from prospective delivery drivers report unactivated accounts after the stated 1-2 business day review window, unanswered emails, an unreachable customer service number and inability to reach a human through the in-app AI chat, with some reviewers calling the company a scam; the app's overall rating is 3.9 from 78 ratings. In 2023 the founder described fundraising as an especially difficult process, citing limited venture capital flowing to Black-founded startups. Third-party data aggregators also circulate inconsistent funding figures for the company.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Related companies · 7
Companies working in the same space as Pills2Me.
Timeline · 4
launches, deals, and filingsApp releases in June 2025 added an AI agent enabling patients to place delivery orders by voice command, followed by an updated assistant model and a driver-facing assistant.
App version 2.9.0 added a diabetes risk assessment in which users answer questions to identify their risk and are referred to CDC-approved institutions for follow up.
Pills2Me, then operating in Las Vegas, Chicago, Houston and New Haven, Connecticut, said it planned to launch in Reno, Phoenix, Dallas, San Antonio, Miami and Tampa by the end of 2023.
Google for Startups awarded Pills2Me approximately $250,000 in resources through its Black Founders Fund — $150,000 in non-dilutive cash and $100,000 in cloud credits — to fund market expansion and hiring. The founder said the award closed the company's pre-seed funding round.
$250K source ↗
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 8
primary sources listed
- Pills2Mepills2me.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Pills2Me do?
- Pills2Me is an on-demand prescription delivery service that picks up medications from any pharmacy and brings them to patients' doors.
- Who founded Pills2Me?
- Pills2Me was founded by Leslie Asanga in 2020.
- Who are Pills2Me's investors?
- Pills2Me's investors include Jumpstart Foundry, Techstars.
- Where is Pills2Me headquartered?
- Pills2Me is headquartered in Las Vegas, US.






